Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 17 Jun 2024 03:58:50 +0200Tue, 04 Jun 2024 12:57:00 +0200Human medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of authorisation: 11/01/2017, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/suliquaHuman medicines European public assessment report (EPAR): Suliqua, insulin glargine,lixisenatide, Date of authorisation: 11/01/2017, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/suliquaTue, 04 Jun 2024 12:57:00 +0200Human medicineSuliqua : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500224675_en.pdfSuliqua : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500224675_en.pdfThu, 30 Mar 2017 02:00:00 +0200Human medicine